A Randomized Trial Comparing a Novel Sirolimus-Eluting Bioresorbable Scaffold withEverolimus-Eluting Metallic Stents in Patients With Coronary Artery Disease: Two-year Clinical Outcomes

被引：0
|
作者：
Han, Yaling [1 ]
Fu, Guosheng [2 ]
Wang, Xiaozeng [1 ]
Xu, Kai [1 ]
Xu, Bo [3 ]
机构：
[1] Gen Hosp Shenyang Mil Reg, Shenyang, Liaoning, Peoples R China
[2] Sir Run Run Shaw Hosp, Hangzhou, Zhejiang, Peoples R China
[3] Fu Wai Hosp, Natl Ctr Cardiovasc Dis, Beijing, Peoples R China
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2018年 / 72卷 / 13期
关键词：
D O I：
10.1016/j.jacc.2018.08.1594
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
TCT-429
引用
收藏
页码：B173 / B173
页数：1
相关论文
共 50 条
  • [31] TWO YEAR CLINICAL OUTCOMES AFTER SIROLIMUS-ELUTING STENT IMPLANTATION FOR THE TREATMENT OF CORONARY ARTERY DISEASE
    Adam, J.
    Harrypaul, A.
    Dyer, R.
    Rmaih, W.
    [J]. CARDIOLOGY, 2013, 126 : 108 - 108
  • [32] Sirolimus-eluting iron bioresorbable scaffold versus cobalt-chromium everolimus-eluting stents in patients with coronary artery disease: Rationale and design of the IRONMAN-II trial
    Song, Lei
    Guan, Changdong
    Yu, Mengyue
    Sun, Zhongwei
    Fu, Guosheng
    He, Yong
    Jia, Shaobin
    Chen, Jiyan
    Qi, Feng
    Bai, Jie
    Li, Wei
    Ge, Junbo
    Han, Yaling
    Gao, Runlin
    [J]. AMERICAN HEART JOURNAL, 2024, 275 : 53 - 61
  • [33] Impact of treatment of coronary artery disease with sirolimus-eluting stents on outcomes of diabetic and nondiabetic patients
    Kuchulakanti, PK
    Torguson, R
    Canos, D
    Rha, SW
    Chu, WW
    Clavijo, L
    Deible, R
    Gevorkian, N
    Suddath, WO
    Satler, LF
    Kent, KA
    Pichard, AD
    Waksman, R
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (08): : 1100 - 1106
  • [34] Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease -: Meta-analysis of randomized trials
    Kastrati, A
    Dibra, A
    Eberle, S
    Mehilli, J
    de Lezo, JS
    Goy, JJ
    Ulm, K
    Schömig, A
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (07): : 819 - 825
  • [35] Outcomes of bare-metal stents implanted simultaneously with sirolimus-eluting stents (Cypher) in multivessel coronary artery disease patients: Evaluation of systemic effects of sirolimus-eluting stents
    Kang, TS
    Yoon, YW
    Hong, BK
    Kwon, HM
    Cho, SY
    Kim, HS
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (8A): : 42A - 42A
  • [36] Two-year results from a Randomized Comparison of Everolimus-Eluting and Sirolimus-Eluting Stents in Patients Treated with Percutaneous Coronary Intervention (SORT OUT IV Trial)
    Jensen, Lisette Okkels
    Thayssen, Per
    Hansen, Henrik S.
    Christiansen, Evald H.
    Maeng, Michael
    Tilsted, Hans-Henrik
    Junker, Anders
    Ravkilde, Jan
    Kaltofi, Anne
    Madsen, Morten
    Soerensen, Henrik T.
    Thuesen, Leif
    Lassen, Jens F.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (20) : B216 - B216
  • [37] 3-Year Clinical Outcomes in the Randomized SORT OUT III Superiority Trial Comparing Zotarolimus- and Sirolimus-Eluting Coronary Stents
    Maeng, Michael
    Tilsted, Hans-Henrik
    Jensen, Lisette Okkels
    Kaltoft, Anne
    Kelbk, Henning
    Abildgaard, Ulrik
    Villadsen, Anton B.
    Krusell, Lars Romer
    Ravkilde, Jan
    Hansen, Knud Norregaard
    Christiansen, Evald Hoj
    Aaroe, Jens
    Jensen, Jan Skov
    Kristensen, Steen Dalby
    Botker, Hans Erik
    Madsen, Morten
    Thayssen, Per
    Sorensen, Henrik Toft
    Thuesen, Leif
    Lassen, Jens Flensted
    [J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2012, 5 (08) : 812 - 818
  • [38] A first-in-man study of the Firesorb Sirolimus Target Eluting Bioresorbable Vascular Scaffold in Patients with Coronary Artery Disease(FUTURE-Ⅰ):two-year clinical and imaging outcomes
    Bo Xu
    Changdong Guan
    Runlin Gao
    [J]. 中国循环杂志, 2018, (S1) : 137 - 137
  • [39] Biodegradable Polymer Versus Permanent Polymer Drug-Eluting Stents and Everolimus- Versus Sirolimus-Eluting Stents in Patients With Coronary Artery Disease 3-Year Outcomes From a Randomized Clinical Trial
    Byrne, Robert A.
    Kastrati, Adnan
    Massberg, Steffen
    Wieczorek, Anna
    Laugwitz, Karl-Ludwig
    Hadamitzky, Martin
    Schulz, Stefanie
    Pache, Juergen
    Fusaro, Massimiliano
    Hausleiter, Joerg
    Schoemig, Albert
    Mehilli, Julinda
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (13) : 1325 - 1331
  • [40] Sirolimus-eluting stents can be used in patients with diabetes and coronary artery disease
    [J]. Nature Clinical Practice Cardiovascular Medicine, 2008, 5 (2): : 68 - 68
12345